leading semaglutide attorney in louisiana gastroparesis law office dallas glp-1 gastroparesis louisiana Louisiana GLP-1 Lawyer Ozempic Leads louisiana semaglutide attorney Liz Murrill – semaglutide gastroparesis attorney in dallas

After washing my face, I didn't feel any tightness

In clinical trials of Ozempic and Wegovy, nausea was reported in: 15.8% of people taking a 0.5 milligram (mg) dose 20.3% of people taking a 1 mg dose 44% of people taking a 2.4 mg dose Nausea is a common side effect of semaglutide, but its also seen with other similar medications in the GLP-1 receptor agonist class

doi: 10.1136/adc.45.242.445

Incretin-based therapies has evidenced a reduced cardiovascular risk in high-risk individuals with type 2 diabetes, independent of the need for additional glucose control

As with any medication, it's important to discuss with a healthcare provider whether a GLP-1 receptor agonist is a suitable option for managing diabetes